Jayson Rieger's most recent trade in Verrica Pharmaceuticals Inc was a trade of 94,311 Common Stock done at an average price of $4.2 . Disclosure was reported to the exchange on Nov. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 25 Nov 2025 | 94,311 | 182,593 (0%) | 0% | 4.2 | 400,114 | Common Stock |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2025 | 23,577 | 23,577 | - | - | Series C Warrant (right to buy) | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 850,000 | 850,000 | - | - | Employee Stock Option (right to buy) | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 280,898 | 832,826 (3%) | 1% | - | Common Stock | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 140,449 | 140,449 | - | - | Series B Warrants (right to buy) | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 140,449 | 140,449 | - | - | Series A Warrants (right to buy) | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2024 | 50,000 | 882,826 (3%) | 0% | 0 | Common Stock | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 2,000,000 | 2,000,000 | - | - | Employee Stock Option (right to buy) |